CL2020001172A1 - Process for the preparation of large isoxazoline particles. - Google Patents

Process for the preparation of large isoxazoline particles.

Info

Publication number
CL2020001172A1
CL2020001172A1 CL2020001172A CL2020001172A CL2020001172A1 CL 2020001172 A1 CL2020001172 A1 CL 2020001172A1 CL 2020001172 A CL2020001172 A CL 2020001172A CL 2020001172 A CL2020001172 A CL 2020001172A CL 2020001172 A1 CL2020001172 A1 CL 2020001172A1
Authority
CL
Chile
Prior art keywords
preparation
isoxazoline
particles
isoxazoline particles
large isoxazoline
Prior art date
Application number
CL2020001172A
Other languages
Spanish (es)
Inventor
George X Zhou
Aaron Cote
Luke Ryan Schenck
Athanas Koynov
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of CL2020001172A1 publication Critical patent/CL2020001172A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Plant Pathology (AREA)
  • Pest Control & Pesticides (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
CL2020001172A 2017-11-07 2020-05-04 Process for the preparation of large isoxazoline particles. CL2020001172A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762582381P 2017-11-07 2017-11-07
US201762608904P 2017-12-21 2017-12-21

Publications (1)

Publication Number Publication Date
CL2020001172A1 true CL2020001172A1 (en) 2020-10-23

Family

ID=64172503

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2020001172A CL2020001172A1 (en) 2017-11-07 2020-05-04 Process for the preparation of large isoxazoline particles.

Country Status (16)

Country Link
US (1) US11858904B2 (en)
EP (1) EP3707129A1 (en)
JP (3) JP7446222B2 (en)
KR (1) KR20200085295A (en)
CN (1) CN111295375A (en)
AU (2) AU2018363686B2 (en)
BR (1) BR112020008848A2 (en)
CA (1) CA3081653A1 (en)
CL (1) CL2020001172A1 (en)
CO (1) CO2020006258A2 (en)
IL (1) IL274075A (en)
MX (1) MX2020004693A (en)
PE (1) PE20210170A1 (en)
PH (1) PH12020500586A1 (en)
UA (1) UA127892C2 (en)
WO (1) WO2019091940A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20201150A1 (en) 2017-11-07 2020-10-26 Intervet Int Bv INJECTABLE PHARMACEUTICAL COMPOSITIONS OF ISOXAZOLINE AND USES OF THE SAME
EP4153133B1 (en) 2020-05-20 2023-11-08 Intervet International B.V. Injectable pharmaceutical compositions and uses thereof
CN112724095A (en) * 2020-09-25 2021-04-30 安徽省公众检验研究院有限公司 Crystal form of fluranide sodium and preparation method thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011764B1 (en) 2004-03-05 2009-06-30 Ниссан Кемикал Индастриз, Лтд. Isoxazoline-substituted benzamide compound and pesticide
TWI412322B (en) 2005-12-30 2013-10-21 Du Pont Isoxazolines for controlling invertebrate pests
TWI430995B (en) 2007-06-26 2014-03-21 Du Pont Naphthalene isoxazoline invertebrate pest control agents
PL2957284T3 (en) 2007-06-27 2018-08-31 E. I. Du Pont De Nemours And Company Animal pest control method
TWI556741B (en) 2007-08-17 2016-11-11 英特威特國際股份有限公司 Isoxazoline compositions and their use as antiparasitics
WO2009063910A1 (en) 2007-11-12 2009-05-22 Nissan Chemical Industries, Ltd. Method for catalytic asymmetric synthesis of optically active isoxazoline compound
TWI411395B (en) 2007-12-24 2013-10-11 Syngenta Participations Ag Insecticidal compounds
JP5564425B2 (en) * 2008-07-09 2014-07-30 日産化学工業株式会社 Process for producing isoxazoline-substituted benzoic acid amide compounds
CA2747060A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
CN102256971B (en) 2008-12-19 2014-09-17 诺华股份有限公司 Isoxazoline derivatives and their use as pesticide
AR077225A1 (en) 2009-06-24 2011-08-10 Organon Nv INJECTABLE FORMULATIONS CONTAINING ASENAPINE AND TREATMENT METHOD THAT USES THEM
JP5679102B2 (en) 2009-08-03 2015-03-04 日産化学工業株式会社 Optically active form and diastereomeric salt of dihydroisoxazole-substituted benzoic acid compound and method for producing the same
TWI487486B (en) 2009-12-01 2015-06-11 Syngenta Participations Ag Insecticidal compounds based on isoxazoline derivatives
DE102010003711B4 (en) * 2010-04-08 2015-04-09 Jesalis Pharma Gmbh Process for the preparation of crystalline active substance particles
ES2566402T3 (en) * 2010-05-27 2016-04-12 E. I. Du Pont De Nemours And Company Crystalline form of 4- [5- [3-Chloro-5- (trifluoromethyl) phenyl] -4,5-dihydro-5- (trifluoromethyl) -3-isoxazolyl] -N- [2-oxo-2 - [(2 , 2,2-trifluoroethyl) amino] ethyl] -1-naphthalenecarboxamide
AU2013245478A1 (en) * 2012-11-01 2014-05-15 Sumitomo Chemical Company, Limited Method for administering agent for controlling ectoparasite to dog
CN105121416B (en) 2013-02-14 2018-12-04 日产化学工业株式会社 The crystalline polymorphic form and its manufacturing method of isoxazoline substituted benzamide compound
JP2015028006A (en) 2013-06-27 2015-02-12 日産化学工業株式会社 Crystalline polymorph of isoxazoline compound and method for producing the same
WO2015048371A1 (en) 2013-09-30 2015-04-02 Zoetis Llc Long-acting spiro-isoxazoline formulations
CN105813651B (en) 2013-12-20 2021-11-23 英特维特国际股份有限公司 Isoxazoline compositions and their use in preventing or treating parasitic infestations of animals
UY36570A (en) 2015-02-26 2016-10-31 Merial Inc INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES OF THE SAME
US20170020848A1 (en) 2015-04-08 2017-01-26 Merial Inc. Extended release injectable formulations comprising an isoxazoline active agent, methods and uses thereof
UY37137A (en) 2016-02-24 2017-09-29 Merial Inc ANTIPARASITARY COMPOUNDS OF ISOXAZOLINE, INJECTABLE FORMULATIONS OF PROLONGED ACTION THAT INCLUDE THEM, METHODS AND USES OF THE SAME
PE20201150A1 (en) 2017-11-07 2020-10-26 Intervet Int Bv INJECTABLE PHARMACEUTICAL COMPOSITIONS OF ISOXAZOLINE AND USES OF THE SAME

Also Published As

Publication number Publication date
PE20210170A1 (en) 2021-01-29
UA127892C2 (en) 2024-02-07
JP2021501755A (en) 2021-01-21
RU2020117583A3 (en) 2021-12-24
BR112020008848A2 (en) 2020-10-20
US11858904B2 (en) 2024-01-02
WO2019091940A1 (en) 2019-05-16
US20200331867A1 (en) 2020-10-22
IL274075A (en) 2020-06-30
CO2020006258A2 (en) 2020-05-29
JP2023099059A (en) 2023-07-11
JP2024010042A (en) 2024-01-23
RU2020117583A (en) 2021-12-08
AU2018363686B2 (en) 2023-11-23
MX2020004693A (en) 2020-08-20
CN111295375A (en) 2020-06-16
JP7446222B2 (en) 2024-03-08
PH12020500586A1 (en) 2021-06-21
EP3707129A1 (en) 2020-09-16
KR20200085295A (en) 2020-07-14
AU2024201160A1 (en) 2024-03-14
CA3081653A1 (en) 2019-05-16
AU2018363686A1 (en) 2020-05-07

Similar Documents

Publication Publication Date Title
DK4050034T3 (en) CD3-BINDING ANTIBODIES
CR20180013A (en) ANTI-TAU ANTIBODIES AND METHODS OF USE.
DK3492632T3 (en) METHODS FOR THE TREATMENT OF LITHIUM-CONTAINING MATERIALS
DK3497081T3 (en) Process for the preparation of 4-ammonium-2,2,6,6-tetraalkylpiperidinyl salts
CR20160362A (en) ANTI-JAGGED1 ANTIBODIES AND METHODS OF USE
FI20146127A (en) Process for the preparation of hydrocarbons
BR112016022976A2 (en) METHODS FOR THE TREATMENT OF HCV
IL263272A (en) Anti-coagulation factor xi antibodies
ES2837136R1 (en) Process for the preparation of 3alpha-hydroxy-5alpha-pregnan-20-one (Brexanolone)
CL2020001172A1 (en) Process for the preparation of large isoxazoline particles.
BR112017003051A2 (en) compound, method for the production of magnetic material
BR112017005126A2 (en) cytotoxic and antimitotic compounds and methods of their use.
CL2019000049A1 (en) Processes for the preparation of 4-alkoxy - (acyl or aquyl) oxy-picolinamide.
MA40859A (en) CADOTRIL PARTICLES
DK3397621T3 (en) Process for the preparation of 1,1,3-trioxo-1,2-benzothiazole-6-carboxamide
DK3215272T3 (en) Process for the preparation of granules which are separated into fractions of different grain size
BR112016024667A2 (en) improved coating compositions and processes for the manufacture thereof
BR112018005299A2 (en) Alkenylphenoxy substituted 1,1-diphenylethylenes, processes for their preparation and use
FR3048968B1 (en) PROCESS FOR THE PREPARATION OF ALKYLAMINES
DK3397620T3 (en) Process for the preparation of 1,1,3-Trioxo-1,2-benzothiazole-6-carboxamide
FR3049599B1 (en) PROCESS FOR THE PREPARATION OF HEXAFLUOROBUTADIENE
ITUB20160480A1 (en) Method for the preparation of Metaraminol.
MA46385A (en) CALCIUM MONOHYDROGENOPHOSPHATE PREPARATION PROCESS
DK3344048T3 (en) Process for the manufacture of dairy powder
FR3024729B1 (en) PROCESS FOR THE PREPARATION OF TRIOXANE